Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Fubang Pharmaceutical is a China-based pharmaceutical company specializing in the development, manufacturing, and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms. Located in the China Medical City in Taizhou, the company focuses on therapeutic areas such as cardiovascular health, anti-infectives, and metabolic disorders. Its product portfolio includes widely used generic medications like Atorvastatin, Rosuvastatin, and Clopidogrel. Fubang Pharmaceutical operates state-of-the-art facilities that comply with national and international GMP standards, positioning itself as a key supplier in the global pharmaceutical supply chain. The company integrates R&D with large-scale production to provide affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Fubang Pharmaceutical.